R Gallily
Overview
Explore the profile of R Gallily including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fisher T, Golan H, Schiby G, PriChen S, Smoum R, Moshe I, et al.
Curr Oncol
. 2016 Mar;
23(2):S15-22.
PMID: 27022310
Background: Neuroblastoma (nbl) is one of the most common solid cancers in children. Prognosis in advanced nbl is still poor despite aggressive multimodality therapy. Furthermore, survivors experience severe long-term multi-organ...
2.
WEISS L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, et al.
Autoimmunity
. 2006 May;
39(2):143-51.
PMID: 16698671
Cannabidinoids are components of the Cannabis sativa (marijuana) plant that have been shown capable of suppressing inflammation and various aspects of cell-mediated immunity. Cannabidiol (CBD), a non-psychoactive cannabidinoid has been...
3.
Moussaieff A, Fride E, Amar Z, Lev E, Steinberg D, Gallily R, et al.
J Ethnopharmacol
. 2005 Jun;
101(1-3):16-26.
PMID: 15963667
The Jerusalem Balsam, a remedy based on an ethanolic extract of a herbal mixture, was formulated in 1719 in the pharmacy of the Saint Savior monastery in the old city...
4.
Lodzki M, Godin B, Rakou L, Mechoulam R, Gallily R, Touitou E
J Control Release
. 2003 Dec;
93(3):377-87.
PMID: 14644587
Cannabidiol (CBD) is a new drug candidate for treatment of rheumatic diseases. However, its oral administration is associated with a number of drawbacks. The objective of this study was to...
5.
WOHLMAN A, Yirmiya R, Gallily R, Weidenfeld J
Neuroimmunomodulation
. 2001 Dec;
9(3):141-7.
PMID: 11752887
Objectives: Mycoplasmas are a group of eubacteria, which cause various diseases in animals and in humans, and can contribute to diseases produced by other infectious agents, particularly HIV. We have...
6.
Brenner T, Pinto F, Abramsky O, Gallily R
Prog Brain Res
. 2001 Sep;
132:499-506.
PMID: 11545014
No abstract available.
7.
Gallily R, Breuer A, Mechoulam R
Eur J Pharmacol
. 2000 Sep;
406(1):R5-7.
PMID: 11011050
2-Arachidonylglycerol (2-AG) inhibits the production in vitro of tumor necrosis factor-alpha (TNF-alpha) by mouse macrophages, as well as in mice. It has no effect on the production of nitric oxide...
8.
Malfait A, Gallily R, Sumariwalla P, Malik A, Andreakos E, Mechoulam R, et al.
Proc Natl Acad Sci U S A
. 2000 Aug;
97(17):9561-6.
PMID: 10920191
The therapeutic potential of cannabidiol (CBD), the major nonpsychoactive component of cannabis, was explored in murine collagen-induced arthritis (CIA). CIA was elicited by immunizing DBA/1 mice with type II collagen...
9.
Gallily R, Brenner T
Inflammation
. 1999 Nov;
23(6):495-505.
PMID: 10565564
Exposure of primary rat glial cells, mostly astrocytes, to heat-inactivated Mycoplasma fermentans triggers the production of tumor necrosis factor alpha (TNFalpha) nitric oxide (NO) and prostaglandin E2 (PGE2). To attenuate...
10.
Trembovler V, Beit-Yannai E, Younis F, Gallily R, Horowitz M, Shohami E
J Interferon Cytokine Res
. 1999 Aug;
19(7):791-5.
PMID: 10454350
Tumor necrosis factor-alpha alpha (TNF-alpha) and reactive oxygen species (ROS) are produced in the brain after traumatic injury and have deleterious effects. In a rat model of closed head injury...